Services

High Quality, High Speed, High-Content

TTP LabTech now offers a new contract screening service based on its proprietary Acumen^® platform. 

High-content screening can be defined as the analysis of fluorescent cellular markers to measure multiple responses to biological stimuli or drug treatment.  It has wide applications in drug discovery covering everything from target identification through to preclinical toxicology.

As the inventors of the Acumen and with extensive experience in high-content screening, TTP LabTech is well placed to apply its expertise and capabilities to new and demanding applications to support the drug discovery process.

Whether your screen is large or small, a one-off or a regular requirement, TTP LabTech can provide the capability you need.  Whether you are new to high-content screening or an expert in the area there is a screening service to suit.

The benefits of our approach include:

• Flexibility - studies are designed around the question(s) you wish to answer
• Quality - all assays are validated prior to embarking on your study
• Speed - on a single instrument we can screen up to 300,000 wells per day so with multiple instruments at our disposal, throughput is never an issue

 For further information on our screening services please contact us at sales@ttplabtech.com

Levels of Service

In order to provide maximum flexibility TTP LabTech offers different levels of service to compliment your existing workflows.

Our Standard Service is the simplest way of accessing Acumen’s powerful assay capabilities.  You run your experiment in-house and then TTP LabTech scans and analyses your plates to deliver raw and/or analysed data rapidly back to you.  This is ideal if you already have regular screens running, but also wish to analyse them using a higher throughput, high-content platform as a rapid primary screen, or simply to access increased capacity.

Our Full Service takes the Standard Service much further. Here we undertake the entire study from cell culture, through compound/reagent exposure to analysis and reporting, including full assay development where required.